367 Best Breast Cancer Doctors Worldwide

Dr. Murat Yaman is a plastic and reconstructive surgeon at Lokman Hekim Istanbul Hospital. He has performed over 1,500 rhinoplasties and 1,500 breast enlargements. Dr. Yaman also completed 500 facelifts and 1,000 liposuction procedures using VASER technology. He works at a JCI-accredited facility that treats 10,000+ patients annually.

• Specializes in tummy tucks, body contouring, and facial feminization surgery.
• Treats 500–600 patients each year for cosmetic and reconstructive needs.
• Member of the Turkish Society of Reconstructive, Aesthetic, and Plastic Surgery.
• Member of the Association of Emergency Hand and Microsurgery.

Dr. Oreste Gentilini has performed 5,000+ breast cancer surgeries at San Raffaele Research Hospital. He specializes in procedures that preserve the breast and lymph nodes. Dr. Gentilini is a leader in preventive surgery for women with high genetic risks. He focuses on treating young women and pregnant patients.

• Heads the Breast Unit and Research Unit at San Raffaele Hospital in Milan.
• Sits on the board of the Italian National Association of Senologists and Surgeons.
• Vice President and founding member of the EU-BREAST organization.
• Authored over 100 scientific papers on breast tumor management.

Dr. Manuela Seifert is the head of the Breast Cancer Center at the Academic Hospital Solingen. She is a double-qualified specialist in breast oncology and reconstructive plastic surgery. Dr. Seifert focuses on preserving the breast by using aesthetic-sparing surgical techniques. She treats patients at a clinic recognized by the German Cancer Society.

• Specializes in 3D mammography, high-precision biopsy, and breast cancer diagnostics.
• Performs breast-conserving operations and post-operative plastic reconstruction.
• Is a member of the German Society of Senology and the Endourological Society.
• Coordinates multidisciplinary care with oncology and radiotherapy departments.

900+ breast cancer procedures over 33 years – Prof. Karagöz specializes in tumor biology and immunotherapy at Anadolu Medical Center.

• Professor of medical oncology with 40+ research publications
• Expert in targeted therapies and cancer immunotherapy
• Head of Medical Oncology at major Turkish hospitals
• Member of Turkish Medical Oncology Association

Dr. Aysel Pasazade is a plastic and reconstructive surgeon at Quartz Hospital in Istanbul. She holds the prestigious EBOPRAS certification. This credential confirms her competence meets high European standards. Dr. Pasazade specializes in complex body and facial transformations.

• Performs deep plane facelifts, rhinoplasty, and mommy makeovers.
• Graduated from Istanbul University Cerrahpaşa Faculty of Medicine.
• Completed residency training at Bursa Uludağ University.
• Treats over 6,500 international patients annually at Quartz Hospital.

Prof. Dr. Kemal Rasa specializes in breast cancer surgery at Anadolu Medical Center, with 29 years of experience and 900+ procedures performed.

• President of the Surgical Infection Society - Europe
• Focuses on minimally invasive breast cancer interventions
• Member of multiple prestigious surgical societies including WSES
• Lecturer at Hacettepe University's General Surgery Department

Dr. Muhammet Mustafa Aydinol is a plastic surgeon at Dr. MED in Istanbul. He specializes in mommy makeovers, BBL, and breast augmentation. Dr. Aydinol is a member of the International Society of Aesthetic Plastic Surgery (ISAPS). He uses VASER and lipomatic techniques for precise body contouring. These methods help create a narrow and athletic abdominal appearance.

• Published research on combining fat injections with implants for breast augmentation.
• Performs specialized procedures including abdominal etching and 360 liposuction.
• Member of the Turkish Society of Plastic, Reconstructive and Aesthetic Surgeons.
• Works at a clinic with a 98.5% success rate for mommy makeover surgeries.

Professor in oncology at Anadolu Medical Center. She served as lead researcher on many international breast cancer clinical studies.

• Specializes in medical oncology and chemotherapy
• Former head of the Medical Oncology Unit at Haydarpaşa Numune Training and Research Hospital
• Completed her medical oncology training at Marmara University – one of Turkey's top programs

Dr. Agusti Barnadas Molins, a leading breast cancer specialist at Teknon Oncology Institute, brings 41 years of experience in clinical oncology and targeted therapies.

• Founding member and Vice President of the Spanish Breast Cancer Research Group (GEICAM)
• Specializes in chemotherapy and immunotherapy for breast cancer
• Member of ESMO, ASCO, and SEOM medical societies
• European Certified in Medical Oncology since 1989

Dr. Cem Yalcinkaya is an associate professor and gynecologic oncologist at Anadolu Medical Center. He specializes in fertility-sparing surgeries and robotic procedures for gynecologic cancers. Dr. Yalcinkaya holds a robotic surgeon certificate for the DaVinci system. He successfully passed the European Society of Gynecologic Oncology (ESGO) exam in 2019.

• Certified robotic surgeon for myomectomy and hysterectomy procedures.
• Completed clinical observations at Charité Berlin and Tel Aviv Chaim Sheba Medical Center.
• Specializes in laparoscopic surgery for endometriosis and ovarian cancer.
• Member of the European Society of Gynaecological Oncology (ESGO) since 2015.

Dr. Ari Raphael leads Israel's national genomic medicine initiative for breast cancer at Sourasky Medical Center.

• Senior physician in breast and lung cancer departments
• Specializes in genomic profiling and liquid biopsies
• Primary investigator for multiple immunotherapy clinical trials
• Outstanding teacher at Tel Aviv University's medical faculty
• Member of ESMO and International Lung Cancer Association

Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.

• President of the Turkish Society for Radiation Oncology.
• Chair of the ESTRO National Societies Committee.
• Recipient of the ASCO International Development and Education Award.
• Author of over 70 international peer-reviewed publications.

Prof. Zielinski has shaped modern cancer treatment over 44 years, leading Austria's largest oncology department and pioneering personalized therapies.

• Published 600+ scientific articles on cancer treatment
• President of the Central European Cooperative Oncology Group (CECOG)
• Medical Director of Wiener Privatklinik's International Oncology Center
• Specializes in individualized cancer therapies and immuno-oncology

Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.

• Authored over 600 peer-reviewed publications in molecular and surgical pathology.
• Specializes in tumor biopsy, immunohistochemistry, and genetic mutation testing.
• Treats complex oncological cases, including glioblastoma and rare sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.

Over 41 years at Sourasky Medical Center specializing in breast cancer – Dr. Merimsky is an Associate Professor and former Chairman of Oncology.

• Extensive research experience in tumor immunology at Felsenstein Medical Research Center
• Published doctoral thesis on lobular carcinoma in situ
• Fellowship in soft tissue and bone sarcoma at Institut Gustave Roussy, Paris
• Active member of ESMO and ASCO with numerous conference participations

Specializes in breast cancer treatments including cytotoxic chemotherapy and immunotherapy – with research focus on improving outcomes.

• Trained at Istanbul University and Cleveland Clinic
• Published multiple studies on breast cancer treatments
• Experienced in hormone therapy and targeted treatments
• Member of international medical community through research

Dr. Luan Tianyan, MD, is Head of Oncology. He was recruited to Hainan Province as a high-level talent. He is a visiting scholar at the Dana-Farber Cancer Institute (USA). He is also Director of the Clinical Research Office at Bozheng Hengda International Hospital. He serves on the standing committees of the Clinical Research Management Committee (Southern Oncology Clinical Research Association), the Immunotherapy Committee (Hainan Provincial Anti-Cancer Association), and the Hainan Province Drug Research Committee.

He has more than 20 years of oncology practice. He provides individualized, comprehensive care for gastrointestinal tumors, lung cancer, and breast cancer. He focuses on pain management, palliative care, and psychological support in advanced cancer. He also works on the clinical use and study of tumor immunotherapy, including personalized mRNA vaccines and CAR-T therapy. He develops and applies proprietary drugs and related technologies.

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Stephanie Lilianne E. Bolle is a radiation oncologist and Head of Radiation Oncology at the Quirónsalud Proton Therapy Center in Madrid. She has led the department since July 2024. The center is Spain’s first proton therapy facility.

MD, University of Liège (1998). Board certified in radiation oncology (2003). She is an active member of the European Society of Paediatric Oncology and works with its Brain Tumor Group and Radiation Oncology Working Group.

She has published more than 120 scientific articles on pediatric brain tumors, proton therapy, pediatric radiation doses, and complex radiotherapy. She takes part in international projects and clinical trials, including BIOMEDE 2 and HARMONIC. Her expertise includes proton therapy, pediatric oncology, CNS and skull base tumors in adults and children, sarcomas, and complex radiotherapy planning.